Charles River Associates (CRA) Sponsors Multiple Presentations on Issues in Life Sciences at ISPOR Europe 2018
“The life sciences specialists at CRA are continually monitoring and analyzing the most recent data and trends affecting the sector as part of our commitment to helping our clients address the issues that affect their operations both regionally and globally,” said CRA Vice President,
Leaders from the CRA Life Sciences Practice will present the following posters in the Exhibit Poster Hall during the ISPOR Europe meeting:
- Title: Impact of Outcome Based Annuities on Small Biotech Companies
Authors:Joseph Nevins withWalter Colasante andLuka Jelcic
Research Poster Presentations: Session I
PCP: Conceptual Papers
Display Hours:8:45 am to 1:45 pm CEST
- Title: The Quantity and Quality of Evidence Supporting European Marketing Authorization of Orphan Drugs: Comparison of Rare Oncology versus Rare Disease
Author:Steven Kelly
Research Poster Presentations: Session I
PSY: Systemic Disorders/Conditions
Display Hours:8:45 am to 1:45 pm CEST
- Title: UK Health Technology Assessment of Orphan Drugs for Rare Oncology versus Rare Disease: Does Orphan Designation Make any Difference in HTA Process?
Author:Steven Kelly
Research Poster Presentations: Session I
PSY: Systemic Disorders/Conditions
Display Hours:8:45 am to 1:45 pm CEST
- Title: Is Adopting a Low Price Strategy to Gain Market Access Compatible with a Viable Gene/Cell Therapy Business?
Author:Walter Colasante
Research Poster Presentations: Session I
PMU: Multiple Diseases
Display Hours:8:45 am to 1:45 pm CEST
- Title: Are Traditional Managed Entry Agreements Suitable for Potentially, Curative Gene/Cell Therapies?
Author:Walter Colasante
Research Poster Presentations: Session III
PHP: Health Care Use & Policy Studies
Display Hours:8:45 am to1:30 pm CEST
- Title: G-BA Conditional Approvals in the AMNOG Procedure: Impact on HTA Outcomes and Price
Authors:Justus Dehnen withDennis Petry ,Fabian Kruse , andJakob Bercher
Research Poster Presentations: Session III
PHP: Health Care Use & Policy Studies
Display Hours:8:45 am to 1:30 pm CEST
- Title: Impact of the Clinical Trial Design Strategy on Product Market Uptake and Overall Commercial Success
Authors:Leanne Finch withCarla Fisher ,Zlatina Dobreva ,Jingyi Huang , andHannah Armstrong
Research Poster Presentations: Session IV
PRM: Research on Methods
Display Hours:3:30 pm to 7:00 pm CEST
About CRA's Life Sciences Practice
The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.
About Charles River Associates (CRA)
Charles River Associates® is a global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about
View source version on businesswire.com: https://www.businesswire.com/news/home/20181106005532/en/
Source:
Charles River Associates
Media Relations, 617-425-6453
media@crai.com
or
Sharon Merrill Associates, Inc.
Jamie Bernard, 617-542-5300
Senior Associate